Victoza Lawsuit

Written By:
Jessie Paluch
Jessie Paluch

Attorney Jessie Paluch, founder of TruLaw, has over 25 years of experience as a personal injury and mass tort attorney, and previously worked as an international tax attorney at Deloitte. Jessie collaborates with attorneys nationwide — enabling her to share reliable, up-to-date legal information with our readers.

This article has been written and reviewed for legal accuracy and clarity by the team of writers and legal experts at TruLaw and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Jessie Paluch, you can do so here.

TruLaw does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us by using the chat on the bottom of this page. This article should not be taken as advice from an attorney.

Victoza Lawsuit Overview

Almost a thousand Victoza lawsuits have been filed against Novo Nordisk, the manufacturer of the medication, for not properly warning the public of potentially serious side effects.


Questions have been raised whether the drug’s benefits outweigh the risks.

The popular prescription type-2 diabetes medication has been linked to life-threatening complications including pancreatitis, pancreatic cancer, gallbladder disease, and thyroid cancer.

Table of Contents

What is Victoza?

Victoza (liraglutide) is in a class of diabetes drugs called incretin mimetics or GLP-1 mimetics.

It is taken once-a-day by injection in the thigh, upper arm, or stomach.

Along with diet and exercise, Victoza works to control blood sugar levels for individuals diagnosed with type-2 diabetes.

It was approved by the FDA in January 2010.

This class of drug works by mimicking an incretin which is a natural hormone that boosts insulin production and regulates blood-sugar levels in the pancreas.

This boost is very important for diabetics in order to keep sugar from building up in the bloodstream.

Other incretin mimetic drugs in the same class are Byetta, Byuderon, Januvia, and Janumet.

Studies have revealed a concern that incretin mimetics may actually increase the risk of pancreatitis and over time pancreatitis is known to increase the risk of pancreatic cancer.

In May 2013, the FDA issued a safety communication linking incretin mimetics to pancreatic disease.

They told the public they were investigating the drug’s link to pancreatic cancer.

What Are The Side Effects Of Victoza?

Side effects of Victoza include, but are not limited to:

  • Pancreatitis
  • Pancreatic Cancer
  • Thyroid Cancer
  • Kidney Impairment or Failure
  • Renal Failure
  • Tumors

The common issue people have experienced include:

  • Nausea
  • Headaches
  • Diarrhea
  • Pain
  • Swelling

FDA Black Box Warning Added To Victoza Label For Thyroid Cancer

The FDA now requires a black boxed warning on the drug’s label, which is the most serious type of warning that can be issued, for the potential development of a rare form of thyroid cancer known as medullary thyroid cancer (MCT).

The active ingredient in Victoza has been shown in laboratory studies to cause thyroid C-cell tumors in the glands of rats and mice – both benign and cancerous.

Tumors have yet to be found in humans, but there is still a concern that Victoza can increase the risk of thyroid cancer.

Can I File A Victoza Lawsuit?

Victoza lawsuits have been centralized in the MDL (multidistrict litigation) No. 2452  in California.

Even though the cases are centralized in one federal court, your case will be looked at on an individual basis.

These lawsuits claim that the manufacturer knew of the serious risks linked to their drug and continued to market it anyway.

If you or a loved one has subsequently been diagnosed with pancreatitis, pancreatic cancer, or thyroid cancer after using Victoza fill out the form on this page so we can discuss your legal options.

The evaluation is completely free.

Written By:
Jessie Paluch
Jessie Paluch

Experienced Attorney & Legal SaaS CEO

With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three.  She spent the first decade of her career working as an international tax attorney at Deloitte.

In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.

In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!

Camp Lejeune Lawsuit

Camp Lejeune’s water contamination issue spanned several decades starting in the 1950s. Exposure to these chemicals has been linked to various serious health issues, including cancer, organ diseases, and death.

Tylenol Lawsuit

Research is increasingly suggesting a link between the use of Tylenol during pregnancy and the development of neurodevelopmental disorders, such as autism and ADHD, in infants.

AFFF Lawsuit

Legal action is being taken against manufacturers of Aqueous Film-Forming Foam (AFFF), a chemical used in fighting fires. The plaintiffs allege that exposure to the foam caused health issues such as cancer, organ damage, and birth and fertility issues.

Do You
Have A Case?

Here, at TruLaw, we’re committed to helping victims get the justice they deserve.

Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.

Would you like our help?

Helpful Sites & Resources